Purdue Pharma LP - Company Profile
Powered by
All the data and insights you need on Purdue Pharma LP in one report.
- Save hours of research time and resources with
our up-to-date Purdue Pharma LP Strategy Report
- Understand Purdue Pharma LP position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Purdue Pharma LP (Purdue) is a pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture, and marketing of prescription medicines and over the counter (OTC) medicines and related healthcare products. Its major product categories include prescription opioids, sedatives for sleep disorders, laxatives, antiseptics, and dietary supplements. Its products offered include Butrans, Hysingla, OxyContin, Senokot, Colace, Peri-Colace, Betadine, and SlowMag. The company also conducts clinical studies on new investigational drugs and pharmaceuticals on the market. The company operates facilities in North Carolina and New Jersey. Purdue is headquartered in Stamford, Connecticut, the US.
Purdue Pharma LP premium industry data and analytics
Products and Services
Products | Brands |
---|---|
- | - |
Antiseptics | Betadine |
Laxatives | Betasept |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Purdue Pharma LP | Hikma Pharmaceuticals Plc | Napp Pharmaceuticals Ltd | Black Diamond Therapeutics Inc | Lannett Co Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United Kingdom | United Kingdom | United States of America | United States of America |
City | Stamford | London | Cambridge | Cambridge | Trevose |
State/Province | Connecticut | England | England | Massachusetts | Pennsylvania |
No. of Employees | - | 8,967 | 194 | 54 | - |
Entity Type | Private | Public | Private | Public | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Craig Landau, PhD. | Chief Executive Officer; President | Senior Management | 2017 | - |
Marcelo Bigal M.D., Ph.D. | Chief Medical Officer | Senior Management | 2018 | - |
Steve Miller | Chairman | Executive Board | 2018 | - |
Edward B. Mahony | Chief Financial Officer; Executive Vice President | Senior Management | 2015 | - |
Julie Ducharme, B.Pharm, M.Sc., Ph.D. | Vice President; Chief Scientific Officer | Senior Management | 2019 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer